NMNH, the reduced form of NMN, is a potent NAD+ precursor.
As the world’s first Self-GRAS approved NMNH, UthPeak™ has completed the world’s largest and longest human clinical trial. The results demonstrate UthPeak™ NMNH’s efficacy in several key areas:
- NAD+ Levels: Increased by 3 times
- Biological Age: Reduced by an average of 5 years
- Energy Levels: Enhanced by 35%
- Emotional Health: Improved by 31%
The Phase II clinical trial will assess UthPeak™ NMNH’s potential for improving sleep quality, cardioprotection, and neuroprotection
